RE: Glanbia down 18.5%26 Feb 2025 16:02
The nutrition market was a money printer a few years ago but now the margins pressures are ramping, and Glanbia even control some of the costs. I would expect this market to get to breakeven or lossmaking in the next decade as biotech advances even further. Competition like this is already a real world problem for Glanbia, having to sell off Slimfast due to the Ozempic surge. I haven't seen much technological advancement in the sports nutrition market for years, it's just the same brands selling the same products with the same formulations with slightly differing flavours and quality.
And Glanbia seem to be in a stronger position than THG Nutrition with Optimum Nutrition +7.5% CCY vs. Myprotein -9%. Also an EBITDA of 17% (120bps YOY) and we will find out Myprotein's in the next couple of months but I would expect it to be flat or slightly down.
This is also super interesting:
"What it actually means is the peak cost we're going to see now in high-end whey in 2025 will be 20% higher than the peak cost we saw post-Covid," Garvey said.
Didn't Matt Moulding say costs were coming down?